CMPS Latest Headlines

Psilocybin shown to ease PTSD in veterans in small study

at seekingalpha.com (Thu, 30-Jul 11:53 AM)

COMP360 Support in PTSD Trial: Study Finds Minimal Interaction Distinct from Traditional Psychotherapy

Market Chameleon (Thu, 16-Jul 7:06 AM)

COMP360 Achieves Rapid and Lasting Results in Treatment-Resistant Depression—39% Show Meaningful Response at Six Months

Market Chameleon (Tue, 7-Jul 7:06 AM)

Compass Pathways Grants New Employee Inducement Awards to Support Talent Growth and Strategic Innovation

Market Chameleon (Thu, 2-Jul 8:11 AM)

Compass Pathways’ Phase 3 Data in Treatment-Resistant Depression Sets the Bar for Novel Depression Therapeutics

Market Chameleon (Fri, 26-Jun 9:44 AM)

Compass Pathways Bolsters Governance as Kathleen Tregoning Joins Board Amid Key FDA Milestones

Market Chameleon (Thu, 28-May 8:40 AM)

Compass Pathways to Spotlight Psilocybin Innovation at Jefferies Global Healthcare Conference—What Should Investors Watch?

Market Chameleon (Tue, 26-May 7:54 AM)

COMPASS Pathways Sees Regulatory Momentum and Strong Financial Position as COMP360 Nears FDA Filing

Market Chameleon (Thu, 14-May 11:47 AM)

Compass Pathways Secures Accelerated FDA Review and Strengthens Cash Position Ahead of Blockbuster Launch for COMP360

Market Chameleon (Wed, 13-May 7:38 AM)